Skip to main content

Table 1 Characteristics of the patients with IBD

From: Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease

 

HC

CD

UC

Number of patients

41

178

75

Age (years)

33.6 ± 10.3

33.7 ± 12.2

41.2 ± 14.9

Gender

 Male

18

115

43

 Female

23

63

32

Active/remission

 

80/98

54/21

Disease duration (months)

 

35.3 ± 16.3

34.4 ± 18.1

Current therapy

 5-Aminosalicylates

 

63

49

 Salazosulfapyridine

 

1

3

 Azathioprine

 

47

6

 Glucocorticoids

 

18

20

 Methotrexate

 

6

4

 Biologics

 

63

2

 Nutritional therapy

 

45

6

Age (CD)a

 A1

 

14

 

 A2

 

122

 

 A3

 

42

 

Disease location (CD)a

 L1

 

57

 

 L2

 

49

 

 L3

 

72

 

Disease behavior (CD)a

 B1

 

99

 

 B2

 

65

 

 B3

 

14

 

 P

 

33

 

Disease phenotype (UC)a

 E1

  

16

 E2

  

23

 E3

  

34

  1. aAccording to the Montreal classification system